1
项与 Amniotic mesenchymal stem cell therapy (Amniotics) 相关的临床试验A First-In-Human Phase 1b, Open-Label Trial to Evaluate Safety and Tolerability of a Novel Somatic Cell Therapy, AmnioPul-02,in Subjects With Confirmed COVID-19 or Other Viral Lower Respiratory Tract Infections
This is a first-in-human (FIH), Phase 1b, open-label, dose-escalation, safety trial consisting of 3 dose levels. Subjects will always be treated in cohorts of size 3, with from 3 up to 6 cohorts i.e. 9-18 subjects.
100 项与 Amniotic mesenchymal stem cell therapy (Amniotics) 相关的临床结果
100 项与 Amniotic mesenchymal stem cell therapy (Amniotics) 相关的转化医学
100 项与 Amniotic mesenchymal stem cell therapy (Amniotics) 相关的专利(医药)
100 项与 Amniotic mesenchymal stem cell therapy (Amniotics) 相关的药物交易